In This Section

Program

Please note that this special conference will take place as an in-person event in Boston and will not live-stream content for virtual participation. The conference content will be recorded and made available as an on-demand program after the conference.

CME credit is available for in-person attendance for the designated sessions. On-demand presentations are not eligible for CME.

All presentations are scheduled to be live, in-person presentations at the date and time specified below unless noted otherwise. Program in progress.

*-Short talk from proffered abstract

Sunday, September 28

monday, September 29

tuesday, September 30

wednesday, october 1

Sunday, September 28

REGISTRATION

3-8 p.m.

WELCOME AND Keynote lectures

5-6:10 p.m.

  • 5 p.m. | Welcome from Conference Cochairs
  • 5:20 p.m. | Keynote Lecture
    Brian M. Wolpin, Dana-Farber Cancer Institute, Boston, Massachusetts
  • 5:50 p.m. | Rising Star Keynote
    Ashley L. Kiemen, Johns Hopkins University of Medicine, Baltimore, Maryland

break

6:30-6:45 p.m.

plenary Session 1: Revolutionizing Early Diagnosis and Prevention

6:40-8:30 p.m.

Session Chair: Laura DeLong Wood, Johns Hopkins University School of Medicine, Baltimore, Maryland

  • 6:45 p.m. | Opportunities with understanding early pancreatic cancer
    Laura DeLong Wood
  • 7:10 p.m. | Elliot Fishman, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • 7:30 p.m. | Florencia McAllister, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • 7:50 p.m. | Developing successful strategies for the early detection of pancreatic adenocarcinoma
    Randall E. Brand, University of Pittsburgh, Pittsburgh, Pennsylvania

OPENING RECEPTION

8:30-10:30 p.m.

Monday, September 29

CONTINENTAL BREAKFAST

7-8 a.m.

cochair highlights

8-8:30 a.m.

Plenary Session 2: Spotlight on New Drug Development

8:30-10:15 a.m.

Session Chair: Eileen M. O’Reilly, Memorial Sloan Kettering Cancer Center, New York, New York

  • 8:35 a.m. | David S. Hong, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • 8:55 a.m. | CRISPR-drug combinatorial screening identifies effective combination treatments for CDKN2A/MTAP-null PDAC
    Kathleen M. Mulvaney, Virginia Polytechnic Institute and State University, Washington, DC
  • 9:15 a.m. | Kim A. Reiss, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania

break

10:15-10:45 a.m.

PLENARY Session 3: Biology of Pancreatic Cancer Progression

10:45 a.m.-12:30 p.m.

Session Chair: Marina Pasca di Magliano, University of Michigan Rogel Cancer Center, Ann Arbor, Michigan

  • 10:50 a.m. | Stress adaptation in pancreatic tumorigenesis
    Elda Grabocka, Thomas Jefferson University, Philadelphia, Pennsylvania
  • 11:10 a.m. | Identifying immune vulnerabilities in pancreatic cancer
    Dieter Saur, Technical University of Munich, Germany
  • 11:30 a.m. | Mutant GNAS drives an indolent phenotype in IPMN by modulating the glycome
    Kathleen E. DelGiorno, Vanderbilt University School of Medicine, Nashville, Tennessee

lunch on own/free time

12:30-2:30 p.m.

Plenary Session Session 4: Harnessing the Immune System to Treat Pancreatic Cancer

2:30-4:15 p.m.

Session Chair: Gregory L. Beatty, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania

  • 2:35 p.m. | Cryptic antigens: Novel targets for TCR-based therapies in pancreas cancer
    William Freed-Pastor, Dana-Farber Cancer Institute, Boston, Massachusetts
  • 2:55 p.m. | Modulating the immunosuppressive stroma: bringing antitumor immune cells back into the game
    Debora Barbosa Vendramini Costa, Michigan State University, Detroit, Michigan

Additional speaker to be announced

Poster session a/reception

4:30-7 p.m.

Tuesday, September 30

CONTINENTAL BREAKFAST

7-8 a.m.

cochair highlights

8-8:30 a.m.

Plenary Session Session 5: Translational Advances to Dissect Pancreatic Cancer Treatment Response

8:30-10:15 a.m.

Session Chair: Manuel Hidalgo, Weill Cornell Medicine, New York, New York

  • 8:35 a.m. | Eric A. Collisson, Fred Hutchinson Cancer Center, Seattle, Washington
  • 8:55 a.m. | Pancreatic cancer phenotypes
    Faiyaz Notta, UHN Princess Margaret Cancer Center, Toronto, ON, Canada
  • 9:15 a.m. | Targeting the oncogenic state of RAS: Lessons from tri-complex inhibitors
    Mallika Singh, Revolution Medicines, Redwood City, California

break

10:15-10:45 a.m.

Plenary Session 6: Tumor Heterogeneity and Evolution

10:45 a.m.-12:15 p.m.

Session Chair: Jen Jen Yeh, University of North Carolina, Chapel Hill, North Carolina

  • 10:50 a.m. | Dana Pe’er, Memorial Sloan Kettering Cancer Center, New York, New York
  • 11:10 a.m. | The “viral-like” behavior of pancreatic cancer
    David T. Ting, Massachusetts General Hospital Cancer Center, Boston, Massachusetts
  • 11:30 a.m. | Deconstructing reciprocal tumour-host interactions in the pancreatic cancer microenvironment
    Claus Jorgensen, Cancer Research UK Manchester Institute, Manchester, England

lunch on own

12:15-3:30 p.m.

Plenary Session 7: New Therapeutic Strategies

3:30-5:45 p.m.

Session Chair: Colin D. Weekes, Massachusetts General Hospital, Boston, Massachusetts

  • 3:35 p.m. | Targeting tumor-nerve interactions in pancreatic cancer
  • William L. Hwang, Massachusetts General Hospital, Boston, Massachusetts
  • 3:55 p.m. | Targeting crosstalking mechanisms supporting pancreatic cancer
    Christopher J. Halbrook, University of California, Irvine, California
  • 4:15 p.m. | Funda Meric-Bernstam, The University of Texas MD Anderson Cancer Center, Houston, Texas

poster session b/reception

5:30-8 p.m.

Wednesday, October 1

CONTINENTAL BREAKFAST

7-8:30 a.m.

Meet-the-Expert / Mentoring Roundtables Session

7:30-8:30 a.m.

No pre-registration is required for this session. Attendance is on a first-come, first-served basis. Participants may rotate to as many tables as they like during the session, providing the opportunity to network and interact with a diverse cadre of experts. Mentors and topics to be announced.

cochair highlights

8:30-9 a.m.

Plenary Session 8: Futuristic Goals in Multimodality Care

9-10:25 a.m.

Session Chair: Alice Wei, Memorial Sloan Kettering Cancer Center, New York, New York

  • 9:05 a.m. | Vaccine therapy in pancreatic cancer
    Kevin C. Soares, Memorial Sloan Kettering Cancer Center, New York, New York
  • 9:25 a.m. | Nina Niu Sanford, University of Texas Southwestern Medical Center, Dallas, Texas
  • 9:45 a.m. | Neeha Zaidi, Johns Hopkins University School of Medicine, Baltimore, Maryland

break

10:25-10:45 a.m.

Plenary Session 9: to be announced

10:45 a.m.-12:15 p.m.

Departure

12:15 p.m.